Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

15.02 -0.29 (-1.89%)
Streaming Delayed Price Updated: 2:47 PM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
From Simulations Plus, Inc.
Via Business Wire
News headline image
Why Simulations Plus Stock Inched Higher Today ↗
The healthcare tech company posted its latest set of quarterly earnings. 
Via The Motley Fool
News headline image
Simulations Plus (SLP) Q2 2026 Earnings Transcript ↗
Simulations Plus (SLP) Q2 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline ↗
Via Chartmill
News headline image
Discover the top movers in Friday's pre-market session. ↗
Wondering what's happening in Friday's pre-market session? Find an overview in this article. 
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in Upcoming Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus (SLP) Q1 2026 Earnings Transcript ↗
Simulations Plus (SLP) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence
The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The... 
Via MarketMinute
Topics Earnings
News headline image
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
From Simulations Plus, Inc.
Via Business Wire
News headline image
Why Shares of Simulations Plus Soared This Week ↗
The stock has taken a beating over the past few years, so expectations may have been low. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Simulations Plus Stock Was Soaring Today ↗
The company's recent performance was broadly in line with expectations; however, if its guidance is accurate, revenue and profitability could rise this fiscal year. 
Via The Motley Fool
News headline image
Which stocks are gapping on Tuesday? ↗
Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
The Crypto Conundrum: Why Digital Asset Treasuries Trade Below Their True Value
November 24, 2025 – In an evolving cryptocurrency landscape, a significant challenge has emerged for companies holding substantial digital assets on their balance sheets: their crypto treasuries often... 
Via BreakingCrypto
Topics Derivatives
News headline image
SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Winnebago Industries, Travel + Leisure, Avery Dennison, Hilton Worldwide And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance
From Simulations Plus, Inc.
Via Business Wire
News headline image
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation – SLP
From The Rosen Law Firm, P.A.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.